1289386-07-7 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
2-Bromomethyl-3-chloro-pyrazine is utilized as a reagent in the preparation of various pharmaceuticals and agrochemicals, contributing to the development of new and effective products in these fields.
Used in Organic Synthesis:
As a building block in organic synthesis, 2-Bromomethyl-3-chloro-pyrazine is employed for the creation of diverse chemical compounds, expanding the scope of chemical research and innovation.
Used in Research and Development:
2-Bromomethyl-3-chloro-pyrazine is used as a research tool in the development of new materials and functional molecules, aiding scientists in exploring its potential applications and properties.
Used in Drug Discovery and Development:
Due to its potential for biological activity, 2-Bromomethyl-3-chloro-pyrazine is of interest to medicinal chemists who are investigating its applications in drug discovery and development, with the aim of identifying new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 1289386-07-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,9,3,8 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1289386-07:
(9*1)+(8*2)+(7*8)+(6*9)+(5*3)+(4*8)+(3*6)+(2*0)+(1*7)=207
207 % 10 = 7
So 1289386-07-7 is a valid CAS Registry Number.
1289386-07-7Relevant academic research and scientific papers
The compounds of structure containing conjugated zincon, its pharmaceutical composition and use thereof (by machine translation)
-
Paragraph 0184-0186, (2018/03/24)
The present invention relates to compounds having a structure containing conjugated zincon, its pharmaceutical composition and use, and in particular relates to the general formula (I) or a salt thereof to the compound represented by the, pharmaceutical compositions thereof, and its as BTK inhibitors and/or B cell activation inhibitor, for the prevention or treatment B cell activity with abnormal and/or the use of the BTK-related diseases. The compounds of lymphoma, breast cancer, liver cancer, colon cancer, gastric cancer, such as lung cancer and cervical cancer cell has better lethal effect, note has potential for the treatment of cancer and self-immune diseases related to potential. (by machine translation)
PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS
-
Page/Page column 18, (2015/05/26)
Pyrido[2,3-d]pyrimidin-4-one compounds, formulations containing those compounds, and their use as tankyrase 1 and 2 inhibitors Formula (I).